Schering GMP Criminal Investigation Continues After Consent Decree
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough faces a potential criminal case regarding GMP violations after finalizing a consent agreement with FDA May 17
You may also be interested in...
Schering CEO Hassan Will Add Personal Touch To Allergy Business Turnaround
Schering-Plough CEO Fred Hassan will be directly involved in reviving the firm's declining allergy business following the Rx-to-OTC switch of Claritin in December 2002
Schering CEO Hassan Will Add Personal Touch To Allergy Business Turnaround
Schering-Plough CEO Fred Hassan will be directly involved in reviving the firm's declining allergy business following the Rx-to-OTC switch of Claritin in December 2002
Schering CEO Hassan Will Add Personal Touch To Allergy Business Turnaround
Schering-Plough CEO Fred Hassan will be directly involved in reviving the firm's declining allergy business following the Rx-to-OTC switch of Claritin in December 2002